Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high‐risk hematopoietic cell transplant recipients
2021 ◽
Vol 27
(3)
◽
pp. S354-S355
2020 ◽
Vol 26
(3)
◽
pp. S317-S318
2016 ◽
Vol 22
(3)
◽
pp. S340
2017 ◽
pp. 1
◽
2016 ◽
Vol 213
(11)
◽
pp. 1701-1707
◽